Blank, Michael, Mathilda Mandel, Naama Dror, Arieh Solomon, Tilda Barlyia, & Dr. Gad Lavie.
" Hypericin targets multiple signaling mediators in cancer cells generating unique, diverse anti-tumoral, anti-metastatic, and anti-angiogenic activities with evidence for clinical applicability." <em>Medical Research Archives</em> [Online], 5.3 (2017): n. pag. Web. 18 Nov. 2024